UPDATE : Wednesday, August 12, 2020
Huons to start trials for BTX in China by Lee Han-soo 2020-05-04 11:30
Boryung to be transformed into anticancer drugmaker by Jeong Sae-im 2020-05-04 10:37
‘Kisqali can treat premenopausal breast cancer patients without removing ovaries’ by Shim Hyun-tai 2020-05-01 16:45
Korean drugmakers’ Q1 earnings rose despite Covid-19 by Jeong Sae-im 2020-05-01 14:45
Kolon to return $12.3 million upfront payment to Mundipharma by Jeong Sae-im 2020-05-01 11:23
GC’s Q1 profit surged amid Covid-19 by Shim Hyun-tai 2020-04-29 18:14
Court rejects Medytox’ request to stop administrative order on BTX suspension by Jeong Sae-im 2020-04-29 17:11
‘Keytruda alone works as first-line therapy for lung cancer’ by Kim Yun-mi 2020-04-29 11:40
‘Pexa-Vec with immunotherapy reduced tumor in 75% of kidney cancer patients’ by Jeong Sae-im 2020-04-28 17:35
Genexine’s cervical cancer DNA vaccine boosts Keytruda’s response rate by Jeong Sae-im 2020-04-28 14:48
Researchers start testing pancreatitis drug to fight Covid-19 by Kim Yun-mi 2020-04-28 11:22
Genexine to present test results at US cancer academy by Shim Hyun-tai 2020-04-27 16:14
‘Parasiticide showed antiviral effect as potential Covid-19 drug’ by Jeong Sae-im 2020-04-24 12:27
French envoy visits Pasteur Korea to watch Covid-19 research by Jeong Sae-im 2020-04-23 17:13
Multinational drugmakers donated ₩30 billion last year by Kim Yun-mi 2020-04-23 15:09
4 drugs recorded two-digit sales growth in Q1 despite Covid-19 by Jeong Sae-im 2020-04-23 12:18
Medytox’s faking data unpunishable due to expired statute of limitations by Jeong Sae-im 2020-04-22 11:28
Abclon derives clinical materials for CAR-T treatment of ovarian cancer by Shim Hyun-tai 2020-04-21 17:49
Multidisciplinary cure is mainstream cancer treatment but cumbersome by Park Gi-taek 2020-04-21 17:09
Whistleblowers, shareholders furious over Medytox’s rebuttal by Jeong Sae-im 2020-04-21 15:19
Back to Top